Jonathan Darrow joined the faculty of Harvard Medical School and the Program on Regulation, Therapeutics, and Law (PORTAL) in 2016, following service as Senior Law Clerk to a judge on the United States Court of Appeals for the Federal Circuit, the court that decides all patent appeals involving pharmaceuticals, biologics, and medical devices. He holds degrees in genetics, law, and business from Cornell, Duke, and Boston College, respectively, as well as a research doctorate in pharmaceutical policy and intellectual property theory from Harvard, where he also completed the LL.M. program. After admission to the bar in 2001, Dr. Darrow worked on emerging company issues in the Silicon Valley and on pharmaceutical litigation matters at a large private firm in Washington, DC. He has since served on the faculties of four universities, and has supported various global heath projects at the Geneva campuses of the World Trade Organization, the World Health Organization, and the World Intellectual Property Organization. He is a co-author of Cyberlaw: Management & Entrepreneurship (2015) and The Legal and Ethical Environment of Business (2d ed. forthcoming 2018). His scholarship on health policy and intellectual property has appeared in the British Medical Journal, the New England Journal of Medicine; the Journal of Law, Medicine & Ethics; the Stanford Technology Law Review; the Yale Journal of Health Policy Law & Ethics, and the Harvard Journal of Law & Technology, among many others.